Preferred Label : Iodine I-124 Girentuximab;
NCIt synonyms : Iodine I 124 Chimeric Monoclonal Antibody G250; I 124 MoAb cG250; 124I-cG250; Iodine I 124 Chimeric Monoclonal Antibody cG250; Iodine (124I) Girentuximab;
NCIt related terms : GIRENTUXIMAB I-124;
NCIt definition : A radioimmunoconjugate comprised of the chimeric monoclonal antibody G250 conjugated
with the positron emitter iodine I 124. The antibody moiety of iodine I 124 chimeric
monoclonal antibody G250 may bind to renal cell carcinoma (RCC) cells that express
the RCC-associated antigen G250, allowing detection of tumor-localized iodine I 124
with positron emission tomography (PET). G250 is a cell surface tumor-associated antigen
(TAA) that is found in the majority of renal cell carcinomas.;
UNII : P0I0FT82VK;
CAS number : 1011710-99-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1011710-99-8
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Redectane;
Molecule name : 124IcG250;
NCI Metathesaurus CUI : CL383142;
Origin ID : C53407;
UMLS CUI : C1708573;
Semantic type(s)
- concept_is_in_subset
- has_target
